ATE.TO
Antibe Therapeutics Inc
Price:  
0.30 
CAD
Volume:  
160,906.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ATE.TO Stock Forecast & Price Target

ATE.TO Stock Price Forecast

The average stock forecast for Antibe Therapeutics Inc (ATE.TO) in the next 12 months is 3.19 CAD. This price target corresponds to an upside of 980.51%. The range of stock forecasts for ATE.TO is 1.51 - 7.35 CAD. Based on the ratings of 8 analysts, the consensus recommendation for ATE.TO is BUY.
Target Low Average Median High
Price (CAD) 1.51 3.19 2.04 7.35
Upside 413.56% 980.51% 591.53% 2,391.53%

Recommendation Trends

The latest consensus rating for ATE.TO is "BUY". This is the average recommendation of 8 analysts: 0 strong sell, 0 sell, 2 hold, 5 buy, 1 strong buy. In the previous period, 8 analysts also majorly recommmended "BUY" for ATE.TO.

ATE.TO Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
-M
from -M
EPS This Year
-0.43
16.02%
from -0.37
EPS Next Year
-0.54
24.71%
from -0.43